Isfahan University of Medical Sciences

Science Communicator Platform

Share Retweet By
Investigation of the Relationship Between Mir-33A, Mir-122, Erythrocyte Membrane Fatty Acids Profile, and Serum Lipids With Components of Metabolic Syndrome in Type 2 Diabetic Patients Publisher

Summary: Higher miR-33a & miR-122 levels in T2DM patients with metabolic syndrome correlate with lipid metabolism issues. #MicroRNAs #MetabolicSyndrome

Masoudi F1 ; Sharifi M2 ; Pourfarzam M1
Authors

Source: Research in Pharmaceutical Sciences Published:2022


Abstract

Background and purpose: MicroRNAs (miRNAs) are small non-coding RNA molecules acting as critical regulators of post-transcriptional gene expression. MiR-33a and miR-122 have a crucial role in cholesterol and lipid metabolism. Therefore, their dysregulation may contribute to metabolic abnormality and their inhibition may be a useful therapeutic strategy. The objective of the present study was to investigate the relationship between miR-33a, miR-122, erythrocyte membrane fatty acids profile, and serum lipids with components of metabolic syndrome in an Iranian population suffering from type 2 diabetes mellitus (T2DM). Experimental approach: Expression of miR-33a and miR-122 was measured by real-time polymerase chain reaction and erythrocyte membrane fatty acid profiles were analyzed by gas chromatography-mass spectrometry. Findings/Results: T2DM patients with and without metabolic syndrome had significantly higher miR-33a and miR-122 levels compared to controls. MiRNAs were significantly correlated with saturated fatty acid (SFAs), total SFAs/total polyunsaturated fatty acids (PUFAs) ratio, fasting plasma glucose, triacylglycerols, insulin and homeostatic model assessment of insulin resistance. In addition, there was a significant negative correlation between miR-33a and miR-122 levels and PUFAs, total PUFAs/total SFAs ratio and omega 6 fatty acids. Conclusion and implications: Considering the roles of miR-33a and miR-122 in cholesterol and lipids metabolism, it may be concluded that the measurement of their expression may be useful as a potential additional biomarker for cardiometabolic derangement in T2DM patients. In addition, these findings may suggest that the inhibition of these miRNAs by anti-miRNA therapies may be explored as a potential therapeutic strategy. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Mir-574, Mir-499, Mir-125B, Mir-106A, and Mir-9 Potentially Target Tgfbr-1 and Tgfbr-2 Genes Involving in Inflammatory Response Pathway: Potential Novel Biomarkers for Chronic Lymphocytic Leukemia, Pathology Research and Practice (2022)
2. Microrna-155 and Exosomal Microrna-155: Small Pieces in the Cardiovascular Diseases Puzzle, Pathology Research and Practice (2024)
3. Can Mir-503 Be Used As a Marker in Diabetic Patients With Ischemic Stroke?, BMC Endocrine Disorders (2019)
Experts (# of related papers)
View all Related Experts
Mohammadreza Sharifi (6)
Rasoul Salehi (5)
Investigation of the Relationship Between Mir-33A, Mir-122, Erythrocyte Membrane Fatty Acids Profile, and Serum Lipids With Components of Metabolic Syndrome in Type 2 Diabetic Patients
Other Related Docs
4. The Potential for Circulating Micrornas in the Diagnosis of Myocardial Infarction: A Novel Approach to Disease Diagnosis and Treatment, Current Pharmaceutical Design (2016)
5. Evaluation of Mir-103 Expression in Peripheral Blood Mononuclear Cells of Type 2 Diabetic and Prediabetic Rats, Journal of Isfahan Medical School (2014)
6. Differential Expression Profile of Mir-27B, Mir-29A, and Mir-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients, Molecular Therapy Oncolytics (2020)
7. Micrornas As the Actors in the Atherosclerosis Scenario, Journal of Physiology and Biochemistry (2020)
8. Modulations of Obesity-Related Micrornas After Exercise Intervention: A Systematic Review and Bioinformatics Analysis, Molecular Biology Reports (2021)
9. The Effect of Beta Interferon on the Expression of Mir-145 in Patients With Multiple Sclerosis, Journal of Isfahan Medical School (2016)
10. Evaluation of Microrna Expression Pattern (Mir-28, Mir-181A, Mir-34A, and Mir-31) in Patients With Covid-19 Admitted to Icu and Diabetic Covid-19 Patients, Intervirology (2023)
11. A Meta-Analysis of Microrna Expression Profiling Studies in Heart Failure, Heart Failure Reviews (2021)
12. Locked Nucleic Acid Inhibits Mir-92A-3P in Human Colorectal Cancer, Induces Apoptosis and Inhibits Cell Proliferation, Cancer Gene Therapy (2016)
13. Role of Micrornas in Pulmonary Hypertension, Horizons in World Cardiovascular Research (2022)
14. Blockage of Mir-92A-3P With Locked Nucleic Acid Induces Apoptosis and Prevents Cell Proliferation in Human Acute Megakaryoblastic Leukemia, Cancer Gene Therapy (2016)
15. Mir-802-5P Is a Key Regulator in Diabetic Kidney Disease, Journal of Research in Medical Sciences (2023)
16. Degradation of Mir-21 Induces Apoptosis and Inhibits Cell Proliferation in Human Hepatocellular Carcinoma, Cancer Gene Therapy (2015)
17. Inducing Cell Proliferative Prevention in Human Acute Promyelocytic Leukemia by Mir-182 Inhibition Through Modulation of Casp9 Expression, Biomedicine and Pharmacotherapy (2017)
18. Inhibition of Microrna Mir-222 With Lna Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia, Indian Journal of Hematology and Blood Transfusion (2017)
19. Dysregulated Mir-103 and Mir-143 Expression in Peripheral Blood Mononuclear Cells From Induced Prediabetes and Type 2 Diabetes Rats, Gene (2015)
20. A Compound Downregulation of Srrm2 and Mir-27A-3P With Upregulation of Mir-27B-3P in Pbmcs of Parkinson’S Patients Is Associated With the Early Stage Onset of Disease, PLoS ONE (2020)